Design of a Carbonic Anhydrase IX Active-Site Mimic To Screen Inhibitors for Possible Anticancer Properties † ‡
about
In vitro evaluation of ESE-15-ol, an estradiol analogue with nanomolar antimitotic and carbonic anhydrase inhibitory activitySignaling pathways of ESE-16, an antimitotic and anticarbonic anhydrase estradiol analog, in breast cancer cellsUltrastructural changes of erythrocytes in whole blood after exposure to prospective in silico-designed anticancer agents: a qualitative case studyTumor acidity as evolutionary spite.Evolution of Tumor Metabolism might Reflect Carcinogenesis as a Reverse Evolution process (Dismantling of Multicellularity).Structural insights into carbonic anhydrase IX isoform specificity of carbohydrate-based sulfamates.Novel estradiol analogue induces apoptosis and autophagy in esophageal carcinoma cells.Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors.Induction of the intrinsic apoptotic pathway via a new antimitotic agent in an esophageal carcinoma cell lineRole of zinc in catalytic activity of carbonic anhydrase IX.A sucrose-binding site provides a lead towards an isoform-specific inhibitor of the cancer-associated enzyme carbonic anhydrase IX.Autophagy induced by a sulphamoylated estrone analogue contributes to its cytotoxic effect on breast cancer cells.Docking, synthesis, and in vitro evaluation of antimitotic estrone analogs.Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors.Structure-Activity Relationships of Benzenesulfonamide-Based Inhibitors towards Carbonic Anhydrase Isoform Specificity.Structure activity study of carbonic anhydrase IX: Selective inhibition with ureido-substituted benzenesulfonamides.
P2860
Q28484595-A68F088E-BB91-4067-98DC-08B94D5A9E42Q28485895-15A73F6F-405B-4D9C-8E32-92893B52DA89Q34204897-079A623A-69B4-40AD-803D-A09F38A66DCBQ34390027-3A5337E0-E745-4F9B-95B1-FDC4DC5DBDA3Q34390032-368E20DB-F16D-4494-8B74-5ECC237751DBQ34394097-031348E4-E45B-49CB-9C03-C2D4C8EC1933Q35100992-709058BE-EDF3-4F5A-BD2A-429DA45E49C1Q35157417-7E23E21D-B77A-4E48-BFDF-C333D4F2E492Q35563305-AB8E9151-5BCE-4911-878F-AB5070E0BE61Q35935908-630A1EAE-6B80-44FD-B725-33D1F5C920ABQ36148199-8B7A06FB-F15E-49AA-AA6B-77AE2E574CA8Q37487830-3CDDECF6-C7C3-4500-AB79-BFEB6549344DQ39606437-12E934FA-AC6E-429A-BF59-2784BC9B9748Q47738911-9B5E7877-8759-4C6C-B9C2-C8ED0D8E6AFCQ48217266-272AEBBC-A817-4B31-ACC5-7EEC0B5C9408Q51079634-40CD5E5A-042D-4058-9FED-401EBF69A836
P2860
Design of a Carbonic Anhydrase IX Active-Site Mimic To Screen Inhibitors for Possible Anticancer Properties † ‡
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Design of a Carbonic Anhydrase ...... ible Anticancer Properties † ‡
@ast
Design of a Carbonic Anhydrase ...... ible Anticancer Properties † ‡
@en
Design of a Carbonic Anhydrase ...... ible Anticancer Properties † ‡
@nl
type
label
Design of a Carbonic Anhydrase ...... ible Anticancer Properties † ‡
@ast
Design of a Carbonic Anhydrase ...... ible Anticancer Properties † ‡
@en
Design of a Carbonic Anhydrase ...... ible Anticancer Properties † ‡
@nl
prefLabel
Design of a Carbonic Anhydrase ...... ible Anticancer Properties † ‡
@ast
Design of a Carbonic Anhydrase ...... ible Anticancer Properties † ‡
@en
Design of a Carbonic Anhydrase ...... ible Anticancer Properties † ‡
@nl
P2093
P2860
P50
P356
P1433
P1476
Design of a Carbonic Anhydrase ...... ible Anticancer Properties † ‡
@en
P2093
Balendu Sankara Avvaru
Caroli Genis
Charles J Rosser
Chingkuang Tu
David N Silverman
Katherine H Sippel
Lawrence J Tartaglia
Nicolette Case
Wengang Cao
P2860
P304
P356
10.1021/BI802035F
P407
P577
2009-02-17T00:00:00Z